These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 29189159)

  • 21. An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells.
    Liu RY; Zhou L; Zhang YL; Huang BJ; Ke ML; Chen JM; Li LX; Fu X; Wu JX; Huang W
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):171-6. PubMed ID: 24269822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathways: multimodal cancer-killing mechanisms employed by oncolytic vesiculoviruses.
    Mahoney DJ; Stojdl DF
    Clin Cancer Res; 2013 Feb; 19(4):758-63. PubMed ID: 23269548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M; Hermiston TW
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncolytic Viruses: Therapeutics With an Identity Crisis.
    Breitbach CJ; Lichty BD; Bell JC
    EBioMedicine; 2016 Jul; 9():31-36. PubMed ID: 27407036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turning killer into cure -- the story of oncolytic herpes simplex viruses.
    Zhang SX
    Discov Med; 2015 Nov; 20(111):303-9. PubMed ID: 26645902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic virotherapy for urological cancers.
    Delwar Z; Zhang K; Rennie PS; Jia W
    Nat Rev Urol; 2016 Jun; 13(6):334-52. PubMed ID: 27215429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Abscopal effect on metastatic tumor induced by oncolytic virus of H101 combining with local heating].
    Hu F; Hu XH; Yu P; Zhang JX; Lou GG; Liu HL; Wu B; Zhao RH; Xia HQ; Wang Y; Chen J; Ben Y; Chen SY
    Ai Zheng; 2006 Aug; 25(8):919-24. PubMed ID: 16965669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of clinical trials assessing oncolytic virus therapy for urological cancers.
    Taguchi S; Fukuhara H; Homma Y; Todo T
    Int J Urol; 2017 May; 24(5):342-351. PubMed ID: 28326624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
    Merrick AE; Ilett EJ; Melcher AA
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1372-82. PubMed ID: 19943208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs and oncolytic viruses.
    Ruiz AJ; Russell SJ
    Curr Opin Virol; 2015 Aug; 13():40-8. PubMed ID: 25863717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress of oncolytic viruses in sarcomas.
    Lettieri CK; Hingorani P; Kolb EA
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):229-42. PubMed ID: 22316371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
    Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of oncolytic measles virus: promises and challenges.
    Galanis E
    Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Trials with Oncolytic Viruses: Current and Future Prospects.
    Patil S; Rao RS; Majumdar B
    J Contemp Dent Pract; 2015 Aug; 16(8):i-ii. PubMed ID: 26423510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer.
    Kasuya H; Kodera Y; Nakao A; Yamamura K; Gewen T; Zhiwen W; Hotta Y; Yamada S; Fujii T; Fukuda S; Tsurumaru N; Kuwahara T; Kikumori T; Koide Y; Fujimoto Y; Nakashima T; Hirooka Y; Shiku H; Tanaka M; Takesako K; Kondo T; Aleksic B; Kawashima H; Goto H; Nishiyama Y
    Hepatogastroenterology; 2014 May; 61(131):599-605. PubMed ID: 26176043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From virotherapy to oncolytic immunotherapy: where are we now?
    Coffin RS
    Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amgen announces oncolytic virus shrinks tumors.
    Sheridan C
    Nat Biotechnol; 2013 Jun; 31(6):471-2. PubMed ID: 23752412
    [No Abstract]   [Full Text] [Related]  

  • 40. Oncolytic vaccinia virus: from bedside to benchtop and back.
    Thorne SH
    Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.